Reuters logo
BRIEF-Rui Kang Pharmaceutical Group Investments says qtrly loss attributable HK$27.9 million
May 10, 2017 / 1:15 PM / 6 months ago

BRIEF-Rui Kang Pharmaceutical Group Investments says qtrly loss attributable HK$27.9 million

May 10 (Reuters) - Rui Kang Pharmaceutical Group Investments Ltd

* Board does not recommend payment of any dividend for three months ended 31 march 2017

* Qtrly turnover HK$34.1 million versus HK$16.6 million

* Qtrly loss attributable HK$27.9 million versus loss of HK$ 11 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below